References
Key articles
Johnston GA, Exton LS, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of contact dermatitis 2017. Br J Dermatol. 2017 Feb;176(2):317-29. Abstract
National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. Mar 2024 [internet publication].Full text
National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. Nov 2021 [internet publication].Full text
Reference articles
1. Knöpfel N, Noguera-Morel L, Latour I, et al. Viral exanthems in children: a great imitator. Clin Dermatol. 2019 May - Jun;37(3):213-26. Abstract
2. van Lier A, Smits G, Mollema L, et al. Varicella zoster virus infection occurs at a relatively young age in The Netherlands. Vaccine. 2013 Oct 17;31(44):5127-33. Abstract
3. Chovel-Sella A, Ben Tov A, Lahav E, et al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics. 2013 May;131(5):e1424-7. Abstract
4. Drago F, Ciccarese G, Gasparini G, et al. Contemporary infectious exanthems: an update. Future Microbiol. 2017 Feb;12:171-93.Full text Abstract
5. Castro MCR, Ramos-E-Silva M. The rash with mucosal ulceration. Clin Dermatol. 2020 Jan - Feb;38(1):35-41. Abstract
6. Repass GL, Palmer WC, Stancampiano FF. Hand, foot, and mouth disease: identifying and managing an acute viral syndrome. Cleve Clin J Med. 2014 Sep;81(9):537-43.Full text Abstract
7. Fölster-Holst R. Infectious exanthemas in childhood. J Dtsch Dermatol Ges. 2020 Oct;18(10):1128-55.Full text Abstract
8. Chuh A, Zawar V, Sciallis GF, et al. Pityriasis rosea, Gianotti-Crosti syndrome, asymmetric periflexural exanthem, papular-purpuric gloves and socks syndrome, eruptive pseudoangiomatosis, and eruptive hypomelanosis: do their epidemiological data substantiate infectious etiologies? Infect Dis Rep. 2016 Mar 21;8(1):6418.Full text Abstract
9. Centers for Disease Control and Prevention. Measles cases and outbreaks: measles cases in 2024. Apr 2024 [internet publication].Full text
10. UK Health Security Agency. National measles standard incident - measles epidemiology (from October 2023). Jun 2024 [internet publication].Full text
11. Karnad DR, Richards GA, Silva GS, et al. Tropical diseases in the ICU: a syndromic approach to diagnosis and treatment. J Crit Care. 2018 Aug;46:119-26. Abstract
12. Freeman EE, McMahon DE, Lipoff JB, et al. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020 Aug;83(2):486-92.Full text Abstract
13. Andina D, Belloni-Fortina A, Bodemer C, et al. Skin manifestations of COVID-19 in children: part 1. Clin Exp Dermatol. 2021 Apr;46(3):444-50. Abstract
14. Almeida G, Arruda S, Marques E, et al. Presentation and management of cutaneous manifestations of COVID-19. J Drugs Dermatol. 2021 Jan 1;20(1):76-83.Full text Abstract
15. Baradaran A, Malek A, Moazzen N, et al. COVID-19 associated multisystem inflammatory syndrome: a systematic review and meta-analysis. Iran J Allergy Asthma Immunol. 2020 Dec 19;19(6):570-88.Full text Abstract
16. Bryant MC, Spencer LT, Yalcindag A. A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature. Pediatr Rheumatol Online J. 2022 Aug 13;20(1):65.Full text Abstract
17. Panda M, Agarwal A, Hassanandani T. Dermatological manifestations of COVID-19 in children. Indian Pediatr. 2022 May 15;59(5):393-9. Abstract
18. Toraih EA, Hussein MH, Elshazli RM, et al. Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis. World J Pediatr. 2021 Apr;17(2):141-51.Full text Abstract
19. Blatz AM, Oboite M, Chiotos K, et al. Cutaneous findings in SARS-CoV-2-associated multisystem inflammatory disease in children. Open Forum Infect Dis. 2021 Mar;8(3):ofab074.Full text Abstract
20. Karadag AS, Elmas ÖF, Altunay İK. Cutaneous manifestations associated with HIV infections: A great imitator. Clin Dermatol. 2020 Mar-Apr;38(2):160-75. Abstract
21. Petersen E, Kantele A, Koopmans M, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019 Dec;33(4):1027-43.Full text Abstract
22. McCollum AM, Shelus V, Hill A, et al. Epidemiology of human Mpox - wworldwide, 2018-2021. MMWR Morb Mortal Wkly Rep. 2023 Jan 20;72(3):68-72.Full text Abstract
23. Huang YA, Howard-Jones AR, Durrani S, et al. Monkeypox: a clinical update for paediatricians. J Paediatr Child Health. 2022 Sep;58(9):1532-8.Full text Abstract
24. National Institute for Health and Care Excellence. Atopic eczema in under 12s: diagnosis and management. Jun 2023 [internet publication].Full text
25. Ho T, Taylor MT, Marathe KS, et al. Most common pediatric skin conditions managed in outpatient dermatology clinics in the United States stratified by race and ethnicity. Pediatr Dermatol. 2021 Nov;38 Suppl 2:129-31.Full text Abstract
26. Victoire A, Magin P, Coughlan J, et al. Interventions for infantile seborrhoeic dermatitis (including cradle cap). Cochrane Database Syst Rev. 2019 Mar 4;(3):CD011380.Full text Abstract
27. Milingou M, Tagka A, Armenaka M, et al. Patch tests in children: a review of 13 years of experience in comparison with previous data. Pediatr Dermatol. 2010 May-Jun;27(3):255-9. Abstract
28. Johnston GA, Exton LS, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of contact dermatitis 2017. Br J Dermatol. 2017 Feb;176(2):317-29. Abstract
29. Marji JS, Marcus R, Moennich J, et al. Use of biologic agents in pediatric psoriasis. J Drugs Dermatol. 2010 Aug;9(8):975-86. Abstract
30. Zawar V. Unilateral pityriasis rosea in a child. J Dermatol Case Rep. 2010 Dec 31;4(4):54-6.Full text Abstract
31. Hay RJ, Steer AC, Engelman D, et al. Scabies in the developing world - its prevalence, complications, and management. Clin Microbiol Infect. 2012 Apr;18(4):313-23. Abstract
32. Fuller LC, Barton RC, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014 Sep;171(3):454-63.Full text Abstract
33. Cohen B. Differential diagnosis of diaper dermatitis. Clin Pediatr (Phila). 2017 May;56(5_suppl):16S-22S.Full text Abstract
34. Lebsing S, Chaiyarit J, Techasatian L. Diaper rashes can indicate systemic conditions other than diaper dermatitis. BMC Dermatol. 2020 Sep 21;20(1):7.Full text Abstract
35. McFee RB. Tick borne illness - Rocky mountain spotted fever. Dis Mon. 2018 May;64(5):185-94. Abstract
36. National Institute for Health and Care Excellence. Lyme disease. Oct 2018 [internet publication].Full text
37. Hoetzenecker W, Nägeli M, Mehra ET, et al. Adverse cutaneous drug eruptions: current understanding. Semin Immunopathol. 2016 Jan;38(1):75-86. Abstract
38. Waldman R, Whitaker-Worth D, Grant-Kels JM. Cutaneous adverse drug reactions: kids are not just little people. Clin Dermatol. 2017 Nov - Dec;35(6):566-82. Abstract
39. Belum VR, Benhuri B, Postow MA, et al. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor. Eur J Cancer. 2016 Jun;60:12-25.Full text Abstract
40. Miliszewski MA, Kirchhof MG, Sikora S, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: an analysis of triggers and implications for improving prevention. Am J Med. 2016 Nov;129(11):1221-5. Abstract
41. Bauer KA, Brimhall AK, Chang TT. Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with azithromycin in acute Epstein-Barr virus infection. Pediatr Dermatol. 2011 Nov-Dec;28(6):741-3. Abstract
42. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol. 2013 May;68(5):693.e1-14; quiz 706-8. Abstract
43. Adwan MH. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and the rheumatologist. Curr Rheumatol Rep. 2017 Jan;19(1):3. Abstract
44. Ramien M, Goldman JL. Pediatric SJS-TEN: where are we now? F1000Res. 2020;9(Faculty Rev):982.Full text Abstract
45. Meningitis Research Foundation. Meningococcal meningitis and sepsis: guidance notes. 2018 [internet publication].Full text
47. Florez-Pollack S, Mauskar MM. Disseminated gonococcal infection. N Engl J Med. 2019 Apr 18;380(16):1565. Abstract
48. Kelchtermans J, Grossar L, Eyskens B, et al. Clinical characteristics of infective endocarditis in children. Pediatr Infect Dis J. 2019 May;38(5):453-8. Abstract
49. Baltimore RS, Gewitz M, Baddour LM, et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young and the Council on Cardiovascular and Stroke Nursing. Infective endocarditis in childhood: 2015 update: a scientific statement from the American Heart Association. Circulation. 2015 Oct 13;132(15):1487-515.Full text Abstract
50. Mazori DR, Nagarajan S, Glick SA. Recurrent reactive infectious mucocutaneous eruption (RIME): insights from a child with three episodes. Pediatr Dermatol. 2020 May;37(3):545-7. Abstract
51. Brewer JD, Hundley MD, Meves A, et al. Staphylococcal scalded skin syndrome and toxic shock syndrome after tooth extraction. J Am Acad Dermatol. 2008 Aug;59(2):342-6. Abstract
52. Strom MA, Hsu DY, Silverberg JI. Prevalence, comorbidities and mortality of toxic shock syndrome in children and adults in the USA. Microbiol Immunol. 2017 Nov;61(11):463-73.Full text Abstract
53. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022 Mar;77(3):734-66.Full text Abstract
54. Najib U, Sheikh J. An update on acute and chronic urticaria for the primary care provider. Postgrad Med. 2009 Jan;121(1):141-51. Abstract
55. Chafen JJ, Newberry SJ, Riedl MA, et al. Diagnosing and managing common food allergies: a systematic review. JAMA. 2010 May 12;303(18):1848-56. Abstract
56. Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatr Clin North Am. 2013 Dec;60(6):1489-511. Abstract
57. Rashtak S, Pittelkow MR. Skin involvement in systemic autoimmune diseases. Curr Dir Autoimmun. 2008;10:344-58. Abstract
58. Webb RH, Grant C, Harnden A. Acute rheumatic fever. BMJ. 2015 Jul 14;351:h3443. Abstract
59. Miyake CY, Gauvreau K, Tani LY, et al. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics. 2007 Sep;120(3):503-8. Abstract
60. Hornor G. Medical evaluation for child physical abuse: what the PNP needs to know. J Pediatr Health Care. 2012 May-Jun;26(3):163-70; quiz 171-3. Abstract
61. Mohandas P, Ravenscroft JC, Bewley A. Dermatitis artefacta in childhood and adolescence: a spectrum of disease. G Ital Dermatol Venereol. 2018 Aug;153(4):525-34. Abstract
62. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10.Full text Abstract
63. National Institute for Health and Care Excellence. Suspected sepsis: recognition, diagnosis and early management. Mar 2024 [internet publication].Full text
64. Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020 Feb;46(suppl 1):10-67.Full text Abstract
65. Schlapbach LJ, Watson RS, Sorce LR, et al. International consensus criteria for pediatric sepsis and septic shock. JAMA. 2024 Feb 27;331(8):665-74.Full text Abstract
66. Royal College of Physicians. National Early Warning Score (NEWS) 2. Dec 2017 [internet publication].Full text
67. American College of Emergency Physicians (ACEP) Expert Panel on Sepsis. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. 2023 [internet publication].Full text
68. Academy of Medical Royal Colleges. Statement on the initial antimicrobial treatment of sepsis. Oct 2022 [internet publication].Full text
69. Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020 Apr;145(4):1082-123.Full text Abstract
70. Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024 Feb;132(2):124-76.Full text Abstract
71. Heckenberg SG, Brouwer MC, van de Beek D, et al. Bacterial meningitis. Handb Clin Neurol. 2014;121:1361-75. Abstract
72. National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. Mar 2024 [internet publication].Full text
73. UK Health Security Agency. Scarlet fever: symptoms, diagnosis and treatment. Mar 2019 [internet publication].Full text
74. UK Health Security Agency. Group A streptococcal infections: activity during the 2022 to 2023 season. Jun 2023 [internet publication].Full text
75. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012 Nov 15;55(10):e86-102.Full text Abstract
76. Committee on Infectious Diseases, American Academy of Pediatrics; Kimberlin DW, Barnett ED, Lynfield R et al. Red Book: 2021–2024 Report of the Committee on Infectious Diseases. 32nd ed. American Academy of Pediatrics; 2021.Full text
77. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009 Mar 24;119(11):1541-51.Full text Abstract
78. UK Health Security Agency. UKHSA update on scarlet fever and invasive group A strep. May 2023 [internet publication].Full text
79. World Health Organization. Increased incidence of scarlet fever and invasive group A streptococcus infection - multi-country. Dec 2022 [internet publication].Full text
80. Dixon G, Christov G. Infective endocarditis in children: an update. Curr Opin Infect Dis. 2017 Jun;30(3):257-67. Abstract
81. Webb R, Voss L, Roberts S, et al. Infective endocarditis in New Zealand children 1994-2012. Pediatr Infect Dis J. 2014 May;33(5):437-42. Abstract
82. Mathur AN, Mathes EF. Urticaria mimickers in children. Dermatol Ther. 2013 Nov-Dec;26(6):467-75. Abstract
83. Tabel Y, Inanc FC, Dogan DG, et al. Clinical features of children with Henoch-Schonlein purpura: risk factors associated with renal involvement. Iran J Kidney Dis. 2012 Jul;6(4):269-74. Abstract
84. Kellogg ND; American Academy of Pediatrics Committee on Child Abuse and Neglect. Evaluation of suspected child physical abuse. Pediatrics. 2007 Jun;119(6):1232-41.Full text Abstract
85. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-99.Full text Abstract
86. Jamieson N, Singh-Grewal D. Kawasaki disease: a clinician's update. Int J Pediatr. 2013;2013:645391.Full text Abstract
87. World Health Organization. Dengue and severe dengue. Mar 2023 [internet publication].Full text
88. World Health Organization, Special Programme for Research and Training in Tropical Diseases (TDR). Dengue: guidelines for diagnosis, treatment, prevention and control. April 2009 [internet publication].Full text
89. National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. Nov 2021 [internet publication].Full text
90. American Academy of Pediatrics. Lyme disease. In: Kimberlin DW, Brady MT, Jackson MA, et al, eds. Red book 2018-2021: report of the Committee on Infectious Diseases. 31st ed. Elk Grove Village, IL: American Academy of Pediatrics; 2018:515-23.
91. UK Health Security Agency. National measles guidelines. Apr 2024 [internet publication].Full text
92. UK Health Security Agency. Measles: the green book, chapter 21. Dec 2019 [internet publication].Full text
93. Kimura H, Shirabe K, Takeda M, et al. The association between documentation of koplik spots and laboratory diagnosis of measles and other rash diseases in a National Measles Surveillance Program in Japan. Front Microbiol. 2019 Feb 18;10:269.Full text Abstract
94. Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States. MMWR Recomm Rep. 2016 May 13;65(2):1-44.Full text Abstract
95. World Health Organization, Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever - revised and expanded edition. 2011 [internet publication].Full text
96. Premaratna R, Pathmeswaran A, Amarasekara ND, et al. A clinical guide for early detection of dengue fever and timing of investigations to detect patients likely to develop complications. Trans R Soc Trop Med Hyg. 2009 Feb;103(2):127-31. Abstract
97. Atanasković-Marković M, Janković J, Tmušić V, et al. Hypersensitivity reactions to antiepileptic drugs in children. Pediatr Allergy Immunol. 2019 Aug;30(5):547-52. Abstract
98. Van den Bruel A, Haj-Hassan T, Thompson M, et al. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010 Mar 6;375(9717):834-45. Abstract
99. Pite H, Wedi B, Borrego LM, et al. Management of childhood urticaria: current knowledge and practical recommendations. Acta Derm Venereol. 2013 Sep 4;93(5):500-8.Full text Abstract
100. Elzagallaai AA, Knowles SR, Rieder MJ, et al. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 2009;32(5):391-408. Abstract
101. Shi YW, Min FL, Zhou D, et al. HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions. Neurology. 2017 Jun 6;88(23):2183-91.Full text Abstract
102. Saito M, Yagi M, Uno K, et al. Comparative study of the usefulness of the drug-induced lymphocyte stimulation test and the leukocyte migration test in drug allergies. Biol Pharm Bull. 2008 Feb;31(2):299-304.Full text Abstract
103. Centres for Disease Control and Prevention. Clinical recognition: key characteristics for identifying Mpox. Mar 2023 [internet publication].Full text
104. MacNeil A, Reynolds MG, Carroll DS, et al. Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo. Am J Trop Med Hyg. 2009 Apr;80(4):503-7. Abstract
105. Hoff NA, Morier DS, Kisalu NK, et al. Varicella coinfection in patients with active monkeypox in the Democratic Republic of the Congo. Ecohealth. 2017 Sep;14(3):564-74.Full text Abstract
106. Hughes CM, Liu L, Davidson WB, et al. A tale of two viruses: coinfections of monkeypox and varicella zoster virus in the Democratic Republic of Congo. Am J Trop Med Hyg. 2020 Dec 7;104(2):604-11.Full text Abstract
107. Cooper JM, Sánchez PJ. Congenital syphilis. Semin Perinatol. 2018 Apr;42(3):176-84.Full text Abstract
108. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015-38. Abstract
109. Menter A, Cordoro KM, Davis DMR, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020 Jan;82(1):161-201.Full text Abstract
110. Chadha A, Jahnke M. Common neonatal rashes. Pediatr Ann. 2019 Jan 1;48(1):e16-e22. Abstract
111. Reginatto FP, Villa DD, Cestari TF. Benign skin disease with pustules in the newborn. An Bras Dermatol. 2016 Apr;91(2):124-34.Full text Abstract
112. Lipozencić J, Wolf R. The diagnostic value of atopy patch testing and prick testing in atopic dermatitis: facts and controversies. Clin Dermatol. 2010 Jan-Feb;28(1):38-44. Abstract
113. World Health Organization. WHO information notice for IVD users 2020/05. Nucleic acid testing (NAT) technologies that use polymerase chain reaction (PCR) for detection of SARS-CoV-2. Jan 2021 [internet publication].Full text
114. Mork RL, Hogan PG, Muenks CE, et al. Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study. Lancet Infect Dis. 2020 Feb;20(2):188-98.Full text Abstract
115. National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. Aug 2020 [internet publication].Full text
116. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992 Aug 6;327(6):380-4.Full text Abstract
117. Goldstein B, Giroir B, Randolph A, et al. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005 Jan;6(1):2-8.Full text Abstract
118. Mahajan P, Grzybowski M, Chen X, et al. Procalcitonin as a marker of serious bacterial infections in febrile children younger than 3 years old. Acad Emerg Med. 2014 Feb;21(2):171-9.Full text Abstract
119. Milcent K, Faesch S, Gras-Le Guen C, et al. Use of procalcitonin assays to predict serious bacterial infection in young febrile infants. JAMA Pediatr. 2016 Jan;170(1):62-9.Full text Abstract
120. Pantell RH, Roberts KB, Adams WG, et al. Evaluation and management of well-appearing febrile infants 8 to 60 Days Old. Pediatrics. 2021 Aug;148(2):e2021052228.Full text Abstract
121. Windfuhr JP, Toepfner N, Steffen G, et al. Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management. Eur Arch Otorhinolaryngol. 2016 Apr;273(4):973-87.Full text Abstract
122. Cohen JF, Bertille N, Cohen R, et al. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev. 2016 Jul 4;7(7):CD010502.Full text Abstract
123. Lean WL, Arnup S, Danchin M, et al. Rapid diagnostic tests for group A streptococcal pharyngitis: a meta-analysis. Pediatrics. 2014 Oct;134(4):771-81. Abstract
124. Barakat AJ, Evans C, Gill M, et al. Rapid strep testing in children with recently treated streptococcal pharyngitis. Pediatr Investig. 2019 Mar;3(1):27-30.Full text Abstract
125. World Health Organization. Clinical management and infection prevention and control for monkeypox: interim rapid response guidance, 10 June 2022. Jun 2022 [internet publication].Full text
126. World Health Organization. Laboratory testing for the monkeypox virus: interim guidance. May 2022 [internet publication].Full text
127. Centers for Disease Control and Prevention. Mpox: clinician FAQs. Feb 2023 [internet publication].Full text
128. World Health Organization. Surveillance, case investigation and contact tracing for mpox (monkeypox): interim guidance, 22 December 2022. Dec 2022 [internet publication].Full text
129. Centers for Disease Control and Prevention. Mpox: case definition. Jul 2022 [internet publication].Full text
Use of this content is subject to our disclaimer